KLP Kapitalforvaltning AS Buys Shares of 24,400 Maximus, Inc. (NYSE:MMS)

KLP Kapitalforvaltning AS purchased a new position in shares of Maximus, Inc. (NYSE:MMS) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 24,400 shares of the health services provider’s stock, valued at approximately $1,821,000.

A number of other large investors have also made changes to their positions in the stock. UMB Bank n.a. grew its position in Maximus by 79.8% during the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock worth $27,000 after buying an additional 158 shares during the period. Eastern Bank purchased a new stake in shares of Maximus during the 4th quarter worth approximately $29,000. V Square Quantitative Management LLC grew its holdings in shares of Maximus by 65.9% in the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider’s stock worth $34,000 after acquiring an additional 180 shares during the period. R Squared Ltd purchased a new position in Maximus in the 4th quarter valued at approximately $54,000. Finally, IFP Advisors Inc raised its holdings in Maximus by 62.4% during the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider’s stock worth $59,000 after purchasing an additional 302 shares during the last quarter. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Insider Buying and Selling at Maximus

In other Maximus news, Director Jan Madsen sold 2,439 shares of the business’s stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the transaction, the director now directly owns 18,097 shares in the company, valued at approximately $1,225,347.87. The trade was a 11.88 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Ilene R. Baylinson sold 14,500 shares of the stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the transaction, the insider now directly owns 2,512 shares in the company, valued at approximately $171,167.68. This represents a 85.23 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

MMS has been the topic of several research reports. StockNews.com lowered Maximus from a “buy” rating to a “hold” rating in a report on Friday, February 14th. Raymond James raised shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective on the stock in a research note on Thursday, January 2nd.

Maximus Trading Up 1.5 %

Shares of MMS opened at $68.06 on Friday. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.97. The stock has a market cap of $3.85 billion, a price-to-earnings ratio of 14.64 and a beta of 0.71. The firm has a 50 day simple moving average of $70.21 and a 200-day simple moving average of $78.02.

Maximus (NYSE:MMS) last released its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Equities analysts forecast that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Saturday, February 15th were paid a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 1.76%. The ex-dividend date was Friday, February 14th. Maximus’s payout ratio is 25.81%.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.